Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients

被引:69
作者
Deramo, VA
Sergott, RC
Augsburger, JJ
Foroozan, R
Savino, PJ
Leone, A
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Wills Eye Hosp, Neuroophthalmol Serv, Philadelphia, PA 19107 USA
[2] Univ Cincinnati, Coll Med, Dept Ophthalmol, Vitreoretinal Serv, Cincinnati, OH USA
[3] Univ Med & Dent New Jersey, Dept Internal Med, Camden, NJ USA
关键词
D O I
10.1016/S0161-6420(03)00079-4
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To investigate the relationship between idiopathic nonarteritic ischemic optic neuropathy (NAION) and serum lipid levels in patients less than or equal to 50 years of age. Design: Case-control study. Participants: Thirty-seven consecutive patients with NAION and 74 age- and gender-matched comparison patients. Methods and Main Outcome Measures: Serum lipid levels and the presence of several historical diseases and exposures were abstracted from the medical records in cases and controls. Results: The mean total cholesterol level was significantly increased in patients with NAION compared with controls (235.4 vs. 204.0 mg/dl, P < 0.001). The odds ratio of having high blood cholesterol (>= 240 mg/dl) with NAION was 3.3 (95% confidence interval, 1.4-7.8), and the likelihood increased when the comparison was restricted to nondiabetic patients. Diabetes mellitus was more common in cases than controls (P = 0.027), but systemic hypertension was not significantly different (P = 0.63). No patient (0 of 24) had a magnetic resonance imaging study consistent with optic neuritis or central nervous system demyelination. Visual improvement was uncommon. Conclusions: This study demonstrates that hypercholesterolemia is associated with NAION in younger patients. NAION may be the first manifestation of a lipid disorder, a previously unrecognized syndrome. These patients have experienced a focal, microvascular central nervous system ischemic event at a relatively young age. Aggressive treatment of lipid abnormalities in these patients may be warranted.
引用
收藏
页码:1041 / 1046
页数:6
相关论文
共 45 条
[1]   COAGULATION ABNORMALITIES IN ISCHEMIC OPTIC NEUROPATHY [J].
ACHESON, JF ;
SANDERS, MD .
EYE, 1994, 8 :89-92
[2]  
BECK RW, 1984, OPHTHALMOLOGY, V91, P1334
[3]   Aspirin therapy in nonarteritic anterior ischemic optic neuropathy [J].
Beck, RW ;
Hayreh, SS ;
Podhajsky, PA ;
Tan, ES ;
Moke, PS .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (02) :212-217
[4]  
BECK RW, 1987, OPHTHALMOLOGY, V94, P1503
[5]   Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults [J].
Berenson, GS ;
Srinivasan, SR ;
Bao, WH ;
Newman, WP ;
Tracy, RE ;
Wattigney, WA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (23) :1650-1656
[6]  
BERI M, 1987, OPHTHALMOLOGY, V94, P1020
[7]   CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS) [J].
BLANKENHORN, DH ;
AZEN, SP ;
KRAMSCH, DM ;
MACK, WJ ;
CASHINHEMPHILL, L ;
HODIS, HN ;
DEBOER, LWV ;
MAHRER, PR ;
MASTELLER, MJ ;
VAILAS, LI ;
ALAUPOVIC, P ;
HIRSCH, LJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) :969-976
[8]   ISCHEMIC OPTIC NEUROPATHY - CLINICAL PROFILE AND NATURAL-HISTORY [J].
BOGHEN, DR ;
GLASER, JS .
BRAIN, 1975, 98 (DEC) :689-&
[9]   REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].
BROWN, G ;
ALBERS, JJ ;
FISHER, LD ;
SCHAEFER, SM ;
LIN, JT ;
KAPLAN, C ;
ZHAO, XQ ;
BISSON, BD ;
FITZPATRICK, VF ;
DODGE, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298
[10]   OPTIC NEUROPATHY OF RECURRENT BLOOD LOSS [J].
CHISHOLM, IA .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1969, 53 (05) :289-&